The U.S. Food and Drug Administration said on Thursday it needs more time to decide whether e-cigarette maker Juul Labs Inc and other major manufacturers can sell their products in the United States.
(Corrects paragraph 1 and 2 to show one patent, not patents)
India's excess deaths during the COVID-19 pandemic could be as high as 4.9 million, a new study shows, providing further evidence that millions more may have died from coronavirus than the official tally. | Video
(Reuters) -The Indian government has ordered 660 million vaccine doses for August-December, its largest procurement, local news reports said on Friday, as state authorities and health experts warned that shortages could leave millions vulnerable if coronavirus infections surge again.
NEW DELHI (Reuters) -A rise in India's COVID-19 infection rate is worrying authorities who are concerned that pilgrimages and tourism could prove to be "superspreader" events in the battle to douse a devastating second wave of infections that has killed thousands.
(Reuters) -Prime Minister Narendra Modi warned on Tuesday against overcrowding at tourist sites and called for faster vaccinations against the coronavirus even as official figures indicated a slower spread of new infections.
Prime Minister Narendra Modi warned on Tuesday against overcrowding at tourist sites and called for faster vaccinations against the coronavirus even as official figures indicated a slower spread of new infections.
NEW DELHI India's COVID-19 deaths relative to infections hit a record high in June after cases peaked in early May, an analysis of government data shows, amid pressure on authorities to accurately report deaths from a second wave of the virus.
(Reuters) -Indian drugmaker Cipla Ltd has received regulatory approval to distribute partner Moderna Inc's COVID-19 vaccine in the country, a senior government official said on Tuesday, clearing the way for the shot to be imported.
BENGALURU Serum Institute of India CEO Adar Poonawalla said on Monday he was trying to resolve EU travel problems facing Indians who have been inoculated with SII's licensed version of AstraZeneca's COVID-19 vaccine.